New search | Conferencedetail
Print view
 
 

4th annual Biosimilars North America

evvnt Platform / evvnt
Conference themes
The first biosimilar product launched in the US in 2015. Currently there are only 4 biosimilar products approved but the North Americas market continues to grow and has become highly lucrative. As such, pharmaceutical companies continue to find ways to differentiate their products in such a saturated market. Thus, Biosimilars North America 2017 will provide an intelligent meeting to explore novel and innovative strategies to advance biosimilar development.
Professional congress organizer (PCO)
SMi Group
 

Enquiries and Registration:

https://go.evvnt.com/130541-1
Ms. Honey de Gracia
 
Categories
Health Services
Languages
English
Congress fees
USD 1.899,00
(Book by June 30: USD 1599 Book by September 29: USD 1799 Standard: USD 1899 Workshop: USD 499)
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

European Public Health Association (EUPHA)Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Ärztekammer für WienHelix - Forschung & Beratung WienAnästhesie in Entwicklungsländern e. V.Ärzte der WeltÖsterreichisches Rotes Kreuz

Facebook

Give us your professional opinion

Start survey

Start survey